COVID-19 cases are surging, underscoring the need to keep using known mitigation strategies. Dr. Tina Q. Tan shares her must-reads from the September issue.
Greetings! I hope everyone had an enjoyable summer and a chance to refresh and recharge as a new school year begins. Over the past month, the delta variant of SARS-CoV-2 has spread throughout the United States, especially in unvaccinated populations. This has caused a surge of COVID-19 infections and a significant increase in COVID-19 hospitalizations among children, with hospitalization rates, as of this writing, 4.6 times higher than they were a month ago. It is important to remember that the COVID-19 pandemic is not over. Please encourage everyone in your offices, hospitals, and elsewhere to continue to wear a mask and follow protective protocols to slow the spread of the virus.
This month’s journal has a number of must-read articles that address frequently encountered issues in pediatric practice. They include:
Thank you for providing outstanding care to your patients during these rapidly changing times. As Ralph Watson stated, “Being positive in a negative situation is not naïve, it’s leadership.”
As always, I welcome your suggestions, comments, and questions.
With warmest regards,
Tina Q. Tan
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.